Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066) [Phase 3]
A Phase 3 trial comparing grazoprevir/elbasvir to boceprevir-based therapy for chronic hepatitis C was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) [Phase 1]
A Phase 1 clinical trial evaluating the hepatic pharmacokinetics of Grazoprevir (MK-5172) in participants with chronic hepatitis C has been …
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease [Phase 4]
A Phase 4 clinical trial evaluating rifaximin for liver scarring in HIV-infected individuals with liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: Boceprevir in End Stage Renal Disease (ESRD) [NA]
A Columbia University-sponsored clinical trial evaluating boceprevir for hepatitis C in patients with end-stage renal disease has been withd…
-
CLINICAL_TRIALS withdrawal · 2015-09-09Clinical Trial Update: Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599) [Phase 3]
Phase 3 clinical trial NCT01641666 evaluating the safety and tolerability of Boceprevir in combination with peginterferon alfa-2b plus ribav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-09-03Clinical Trial Update: Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C
A prospective observational registry evaluating Infergen (interferon alfacon-1) for Hepatitis C has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-17Clinical Trial Update: An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis. [Phase 2]
Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of 12 weeks of Simeprevir plus Daclatasvir in chronic hepa…
-
CLINICAL_TRIALS withdrawal · 2015-06-25Clinical Trial Update: Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C [Phase 1]
The Phase 1 trial evaluating Sho-saiko-to for reducing hepatitis C viral load was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Safety Study of Raltegravir in HIV/HCV Co-infected Patients [Phase 4]
A Phase 4 safety study of raltegravir in patients co-infected with HIV and hepatitis C has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Rosuvastatin for Hepatitis C [NA]
A clinical trial evaluating rosuvastatin for hepatitis C conducted by UMC Utrecht has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-09Clinical Trial Update: Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis [NA]
This clinical trial evaluated the impact of changing HIV therapy on liver steatosis, inflammation, and fibrosis in individuals with HIV and …
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C [Phase 2, Phase 3]
A Phase 2/3 randomized study evaluating silibinin (Legalon SIL) in treatment-naive genotype 4 chronic hepatitis C patients has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2015-01-28Clinical Trial Update: The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
The ROLFH study investigating regression of liver fibrosis and risk for hepatocellular carcinoma in chronic hepatitis C and chronic hepatiti…
-
CLINICAL_TRIALS withdrawal · 2015-01-09Clinical Trial Update: A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers [Phase 1]
Phase 1 drug interaction study of Boceprevir with amlodipine or diltiazem in healthy volunteers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Cell Bound Complement Activation Proteins as Markers of Liver Injury
A clinical trial evaluating cell-bound complement activation proteins as biomarkers of liver injury in Hepatitis C has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-10-08Clinical Trial Update: SIMpill Medication Dispensing Device in the Treatment of HCV
The clinical trial evaluating the SIMpill Medication Dispensing Device for chronic hepatitis C infection has been withdrawn.
-
EMA withdrawal · 2014-09-16EMA Application withdrawn: Faldaprevir Boehringer Ingelheim (faldaprevir) — Boehringer Ingelheim International GmbH
The EMA withdrew the application for faldaprevir by Boehringer Ingelheim International GmbH for chronic hepatitis C.
-
CLINICAL_TRIALS withdrawal · 2014-08-13Clinical Trial Update: Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers [Phase 4]
Phase 4 clinical trial evaluating Hepatitis C virus post-exposure prophylaxis for health care workers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-08-13Clinical Trial Update: Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) [Phase 3]
Phase 3 trial evaluating low-dose maintenance peginterferon alfa-2b versus supportive care in patients with cirrhotic hepatitis C and HIV ha…
-
CLINICAL_TRIALS withdrawal · 2014-08-11Clinical Trial Update: An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)
An observational study of chronic hepatitis C patients treated with PegIntron and Rebetol in Belgium has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-23Clinical Trial Update: Evaluation of the National Treatment Program of Hepatitis C in Egypt
A clinical trial evaluating Egypt's National Treatment Program for chronic Hepatitis C has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-14Clinical Trial Update: Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a combination of Vitamin D, telaprevir, peginterferon, and ribavirin for Hepatitis C genotype 1 …
-
CLINICAL_TRIALS withdrawal · 2014-05-09Clinical Trial Update: Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C [Phase 2]
Phase 2b trial of BMS-986094 and daclatasvir for chronic hepatitis C has been withdrawn, with or without ribavirin.
-
CLINICAL_TRIALS withdrawal · 2014-04-17Clinical Trial Update: Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump [Phase 1, Phase 2]
A phase 1/2 trial evaluating sustained interferon alfa-2b therapy delivered via the InfraDure Biopump for relapsing Hepatitis C has been wit…
-
CLINICAL_TRIALS withdrawal · 2014-04-01Clinical Trial Update: Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
A clinical trial evaluating cellular immune responses in the liver of patients with chronic hepatitis C has been withdrawn.